Lysophosphatidylcholine increases C-type natriuretic peptide expression in human vascular smooth muscle cells via membrane distortion

Vascular Pharmacology

Volumn 51, Issue 1, 2009, Pages 29-36

  Mendonça, Maria C ^a   Rezende, Adriana ^a   Doi, Sonia Q ^a   Sellitti, Donald F ^a  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

C type natriuretic peptide; Endothelial cells; Low density lipoprotein; Lysophosphatidylcholine; Vascular smooth muscle cells

Indexed keywords

1,2 BIS(2 AMINOPHENOXY)ETHANE N,N,N',N' TETRAACETIC ACID TETRA(ACETOXYMETHYL) ESTER; CALCIUM; CHOLESTEROL; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLCHOLINE; MESSENGER RNA; METHYL BETA CYCLODEXTRIN; NATRIURETIC PEPTIDE TYPE C; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

AORTA; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL MEMBRANE; CHELATION; COMPLEX FORMATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MEMBRANE DAMAGE; MEMBRANE STABILIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTENOSIS; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; VASCULAR SMOOTH MUSCLE;

CELL MEMBRANE; GENE EXPRESSION REGULATION; HUMANS; LYSOPHOSPHATIDYLCHOLINES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NATRIURETIC PEPTIDE, C-TYPE;

EID: 67349162091     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2009.01.010     Document Type: Article

References (31)

1. Abbey S.E., and Potter L.R. Lysophosphatidic acid inhibits C-type natriuretic peptide activation of guanylyl cyclase-B. Endocrinology 144 (2003) 240-246
2. Abbey-Hoesch S.E., Cody A.N., and Potter L.R. Sphingosine-1-phosphate inhibits C-type natriuretic peptide activation of guanylyl cyclase B (GC-B/NPR-B). Hypertension 43 (2004) 1103-1109
3. Baldini P.M., De Vito P., D', aquilio F.D., Vismara D., Zalfa F., Bagni C., Fiaccavento R., and Di Nardo P. Role of atrial natriuretic peptide in the suppression of lysophosphatidic acid-induced rat aortic smooth muscle (RASM) cell growth. Mol. Cell. Biochem. 272 (2005) 19-28
4. 2+ influx, enhanced DNA synthesis and cytotoxicity in cultured vascular smooth muscle cells. Atherosclerosis 112 (1995) 69-76
5. Christian A.E., Haynes M.P., Phillips M.C., and Rothblat G.H. Use of cyclodextrins for manipulating cellular cholesterol content. J. Lipid Res. 38 (1997) 2264-2272
6. Cieslik K., Zembowicz A., Tang J.L., and Wu K.K. Transcriptional regulation of endothelial nitric-oxide synthase by lysophosphatidylcholine. J. Biol. Chem. 273 (1998) 14885-14890
7. Heinecke J.W., Rosen H., and Chait A. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J. Clin. Invest. 74 (1984) 1890-1894
8. Hutchinson H.G., Trindade P.T., Cunanan D.B., Wu C.F., and Pratt R.E. Mechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells. Cardiovasc. Res. 35 (1997) 158-167
9. Kelsall C.J., Chester A.H., Sarathchandra P., and Singer D.R. Expression and localization of C-type natriuretic peptide in human vascular smooth muscle cells. Vasc. Pharmacol. 45 (2006) 368-373
10. Kogure K., Nakashima S., Tsuchie A., Tokumura A., and Fukuzawa K. Temporary membrane distortion of vascular smooth muscle cells is responsible for their apoptosis induced by platelet-activating factor-like oxidized phospholipids and their degradation product, lysophophatidylcholine. Chem. Phys. Lipids 126 (2003) 29-38
11. Kohno M., Yokokawa K., Yasunari K., Kano H., Minami M., Ueda M., and Yoshikawa J. Effect of natriuretic peptide family on the oxidized LDL-induced migration of human coronary artery smooth muscle cells. Circ. Res. 81 (1997) 585-590
12. Kohno M., Yasunari K., Maeda K., Kano H., Minami M., Hanehira T., and Yoshikawa J. Effects of cardiac natriuretic peptides on oxidized low density lipoprotein- and lysophosphatidylcholine-induced human mesangial cell migration. Hypertension 35 (2000) 971-977
13. Kougias P., Chai H., Lin P.H., Lumsden A.B., Yao Q., and Chen C. Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis. Med. Sci. Monit. 12 (2006) RA5-RA16
14. Madhusoodanan K.S., Guo D., McGarrigle D.K., Maack T., and Huang X.Y. Csk mediates G-protein-coupled lysophosphatidic acid receptor-induced inhibition of membrane-bound guanylyl cyclase activity. Biochemistry 45 (2006) 3396-3403
15. Mendonça M.C., Doi S.Q., Glerum S., and Sellitti D.F. Increase of C-type natriuretic peptide expression by serum and platelet-derived growth factor-BB in human aortic smooth muscle cells is dependent on protein kinase C activation. Endocrinology 147 (2006) 4169-4178
16. Müller D., Cortes-Dericks L., Budnik L.T., Brunsig-Spickenheier B., Pancratius M., Speth R.C., Mukhopadhyay A.K., and Middendorff R. Homologous and lysophophatidic acid-induced desensitization of the atrial natriuretic peptide receptor, guanylyl cyclase-A, in MA-10 Leydig cells. Endocrinology 147 (2006) 2974-2985
17. Naruko T., Ueda M., van der Wal A.C., van der Loos C.M., Itoh H., Nakao K., and Becker A.E. C-type natriuretic peptide in human coronary atherosclerotic lesions. Circulation 94 (1996) 3103-3108
18. Naruko T., Itoh A., Haze K., Ehara S., Fukushima H., Sugama Y., Shirai N., Ikura Y., Ohsawa M., and Ueda M. C-type natriuretic peptide and natriuretic peptide receptors are expressed by smooth muscle cells in the neointima after percutaneous coronary intervention. Atherosclerosis 181 (2005) 241-250
19. Ogawa Y., Itoh H., Yoshitake Y., Inoue M., Yoshimasa T., Serikawa T., and Nakao K. Molecular cloning and chromosomal assignment of the mouse C-type natriuretic peptide (CNP) gene (Nppc): comparison with the human CNP gene (NPPC). Genomics 24 (1994) 383-387
20. Potter L.R., Abbey-Hoesch S., and Dickey D.M. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr. Rev. 27 (2006) 47-72
21. Rong J.X., Shapiro M., Trogan E., and Fisher E.A. Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading. Proc. Natl. Acad. Sci. 100 (2003) 13531-13536
22. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
23. Scotland R.S., Ahluwalia A., and Hobbs A.J. C-type natriuretic peptide in vascular physiology and disease. Pharmacol. Ther. 105 (2005) 85-93
24. Scotland R.S., Cohen M., Foster P., Lovell M., Mathur A., Ahluwalia A., and Hobbs A.J. C-type natriuretic peptide inhibits leukocyte recruitment and platelet-leukocyte interactions via suppression of P-selectin expression. Proc. Natl. Acad. Sci. 102 (2005) 14452-14457
25. Shinomiya M., Tashiro J., Saito Y., Yoshida S., Furuya M., Oka N., Tanaka S., Kangawa K., and Matsuo H. C-type natriuretic peptide inhibits intimal thickening of rabbit carotid artery after balloon catheter injury. Biochem. Biophys. Res. Commun. 205 (1994) 1051-1056
26. Siess W., Zangl K.J., Essler M., Bauer M., Brandl R., Corrinth C., Bittman R., Tigyi G., and Aepfelbacher M. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc. Natl. Acad. Sci. 96 (1999) 6931-6936
27. Sugiyama S., Kugiyama K., Matsumura T., Suga S., Itoh H., and Nakao K. Yasue H. Lipoproteins regulate C-type natriuretic peptide secretion from cultured vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 15 (1995) 1968-1974
28. Tamama K., Tomura H., Sato K., Malchinkhuu E., Damirin A., Kimura T., Kuwabara A., Murakami M., and Okajima F. High-density lipoprotein inhibits migration of vascular smooth muscle cells through its sphingosine 1-phosphate component. Atherosclerosis 178 (2005) 19-23
29. Woodard G.E., Rosado J.A., and Brown J. Expression and control of C-type natriuretic peptide in rat vascular smooth muscle cells. Am. J. Physiol., Regul. Integr. Comp. Physiol. 282 (2002) R156-R165
30. Zhang Z., Xiao Z., and Diamond S.L. Shear stress induction of C-type natriuretic peptide (CNP) in endothelial cells is independent of NO autocrine signaling. Ann. Biomed. Eng. 27 (1999) 419-426
31. Zhou L., Shi M., Guo Z., Brisbon W., Hoover R., and Yang H. Different cytotoxic injuries induced by lysophosphatidylcholine and 7-ketocholesterol in mouse endothelial cells. Endothelium 13 (2006) 213-226